| Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP) (NCT01284582) | Affiris AG | 2011-05-01 |
| Performance and Safety Evaluation of an Intradermal Delivery Device (NCT01359111) | PATH | 2011-05-01 |
| A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors (NCT01325558) | Altor BioScience | 2011-05-01 |
| Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy (NCT01703143) | Mayo Clinic | 2011-05-01 |
| Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 (NCT01348516) | Kainos Medicine Inc. | 2011-05-01 |
| A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors (NCT01345201) | OncoMed Pharmaceuticals, Inc. | 2011-05-01 |
| Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine (NCT01353534) | Intercell USA, Inc. | 2011-05-01 |
| Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects (NCT01520987) | Bial - Portela C S.A. | 2011-05-01 |
| A Phase 1 Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Tivozanib in Healthy Subjects (NCT01363804) | AVEO Pharmaceuticals, Inc. | 2011-05-01 |
| Study of IMF-001 in Patients With Malignancies Expressing NY-ESO-1 (NCT01234012) | ImmunoFrontier, Inc. | 2011-05-01 |
| Cisplatin and Pemetrexed With Radiation Followed by Lobectomy (NCT01373463) | Medical University of South Carolina | 2011-05-01 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies (NCT01419704) | Talaris Therapeutics Inc. | 2011-05-01 |
| Bioavailability of Two Doses of cogniVida™ With One Dose of Rebaudioside A in Healthy Male Subjects (NCT01403233) | dsm-firmenich Switzerland AG | 2011-05-01 |
| OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study (NCT01643772) | Mundipharma (China) Pharmaceutical Co. Ltd | 2011-05-01 |
| Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444 (NCT01603238) | LG Life Sciences | 2011-05-01 |
| Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers (NCT01375946) | Agile Therapeutics | 2011-05-01 |
| Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects (NCT01323062) | UNC Lineberger Comprehensive Cancer Center | 2011-05-01 |
| Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069 (NCT01332903) | AstraZeneca | 2011-05-01 |
| Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors (NCT01357330) | Sanofi | 2011-05-01 |
| A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers (NCT01362764) | Cougar Biotechnology, Inc. | 2011-05-01 |
| Oral Ketamine for Control of Chronic Pain in Children (NCT01369680) | University of Rochester | 2011-05-01 |
| Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition (NCT01578252) | IPCA Laboratories Ltd. | 2011-05-01 |
| Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects (NCT01354782) | AstraZeneca | 2011-05-01 |
| Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy Adults (NCT01345864) | Pfizer | 2011-05-01 |
| Effects of TT301 on Cytokine Levels Post Endotoxin Challenge (NCT01357421) | OPKO Health, Inc. | 2011-05-01 |
| Skin Test Study of BM32 (NCT01350635) | Biomay AG | 2011-05-01 |
| A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age (NCT01165580) | Hoffmann-La Roche | 2011-05-01 |
| Haploidentical NK-cell Infusion in Acute Myeloid Leukemia (NCT01947322) | Assistance Publique - Hôpitaux de Paris | 2011-05-01 |
| L-citrulline Supplementation & Cold Exposure (NCT01462591) | Florida State University | 2011-05-01 |
| High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy (NCT01334879) | The New York Eye Cancer Center | 2011-05-01 |
| To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. (NCT01381341) | Abbott | 2011-05-01 |
| Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer (NCT01423123) | NSABP Foundation Inc | 2011-05-01 |
| A Study on the Effect of Food on the Pharmacokinetics of RO5428029 in Healthy Volunteers (NCT01345942) | Hoffmann-La Roche | 2011-05-01 |
| Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis (NCT01370902) | Innate Pharma | 2011-05-01 |
| Dose-effect Relationship of Low-dose IL-2 in Type 1 Diabetes (NCT01353833) | Assistance Publique - Hôpitaux de Paris | 2011-05-01 |
| Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT01390818) | EMD Serono | 2011-05-01 |
| Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects (NCT01462708) | Institute for Neurodegenerative Disorders | 2011-05-01 |
| The Effects of Sedative on the Fluid Responsiveness in Critically Ill Patients (NCT01447875) | Southeast University, China | 2011-05-01 |
| A Phase 1 Study to Evaluate The Effect of Ketoconazole on the Pharmacokinetics of Tivozanib in Healthy Subjects (NCT01363778) | AVEO Pharmaceuticals, Inc. | 2011-05-01 |
| Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis (NCT01416493) | Alloksys Life Sciences B.V. | 2011-05-01 |
| Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy Subjects (NCT01340183) | AstraZeneca | 2011-05-01 |
| Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid (NCT01349647) | Memorial Sloan Kettering Cancer Center | 2011-05-01 |
| Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules (NCT02680132) | Torrent Pharmaceuticals Limited | 2011-05-01 |
| A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001 (NCT01403155) | Inovio Pharmaceuticals | 2011-05-01 |
| A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON) (NCT01300247) | Genentech, Inc. | 2011-05-01 |
| The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru (NCT01338051) | Preventive Oncology International, Inc. | 2011-05-01 |
| Effects of Pregabalin on Pain After Total Knee Arthroplasty (NCT01333956) | Hospital for Special Surgery, New York | 2011-05-01 |
| An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites (NCT01330472) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-05-01 |
| Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer (NCT01348009) | Genta Incorporated | 2011-05-01 |
| Pharmacokinetic Study to Characterize Phenotyping Metrics of the "Basel" Cocktail After CYP Induction or Inhibition (NCT01386593) | University Hospital, Basel, Switzerland | 2011-05-01 |
| PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations. (NCT01297088) | Lantheus Biosciences Ltd. | 2011-05-01 |
| A Study of RO4995819 in Combination With Citalopram in Healthy Volunteers (NCT01367756) | Hoffmann-La Roche | 2011-05-01 |
| Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors (NCT01970553) | PharmaMar | 2011-05-01 |
| Cell Therapy for Venous Leg Ulcers Pilot Study (NCT01750749) | Hospital de Clínicas Dr. Manuel Quintela | 2011-05-01 |
| Biomarkers of Cockroach Sublingual Immunotherapy 2 (NCT01380327) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Clinical Trial for Evaluation of Ethnic Differences in Pharmacokinetics of Chloroquine, an Anti-malarial Drug (NCT01366235) | Asan Medical Center | 2011-05-01 |
| Alefacept in Patients With Relapsed/Refractory Aplastic Anemia (NCT01267643) | The Cleveland Clinic | 2011-05-01 |
| PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions (NCT01362673) | Pfizer | 2011-05-01 |
| A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception (NCT02173808) | Premier Research | 2011-05-01 |
| Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers (NCT01350921) | AstraZeneca | 2011-05-01 |
| Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer Survivors (NCT01324102) | VA Office of Research and Development | 2011-05-01 |
| Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers (NCT01347086) | Boehringer Ingelheim | 2011-05-01 |
| Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies (NCT01658319) | Case Comprehensive Cancer Center | 2011-05-01 |
| Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players (NCT01834547) | K. Lieb | 2011-05-01 |
| H5N1 Mix and Match With AS03 (NCT01317758) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects (NCT01362712) | Siemens Molecular Imaging | 2011-05-01 |
| Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV) (NCT01290133) | Accenture | 2011-05-01 |
| A Study of LY2523355 in Patients With Solid Cancer (NCT01358019) | Kyowa Kirin Co., Ltd. | 2011-05-01 |
| A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics (NCT01833923) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2011-05-01 |
| Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers (NCT01351129) | Pfizer | 2011-05-01 |
| Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C (NCT02309086) | Clinica Universidad de Navarra, Universidad de Navarra | 2011-05-01 |
| Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer (NCT01270698) | Gilead Sciences | 2011-05-01 |
| A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis (NCT01465529) | AlgiPharma AS | 2011-05-01 |
| Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions. (NCT02962336) | Torrent Pharmaceuticals Limited | 2011-05-01 |
| Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel) (NCT01327911) | Neurotech Pharmaceuticals | 2011-05-01 |
| Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis (NCT01262118) | Pfizer | 2011-05-01 |
| A Study of LY2495655 in Healthy Subjects (NCT01341470) | Eli Lilly and Company | 2011-05-01 |
| A Study of Safety and Tolerability in Subjects With Schizophrenia (NCT01354353) | Denovo Biopharma LLC | 2011-05-01 |
| Effect of Platelet Rich Plasma on Photoaged Skin (NCT01372566) | Northwestern University | 2011-05-01 |
| A Safety Study of ARRY-502 in Healthy Subjects (NCT01349725) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2011-05-01 |
| Multiple Ascending Dose Study of SPC4955 in Healthy Subjects (NCT01365663) | Santaris Pharma A/S | 2011-05-01 |
| Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma (NCT01273090) | Children's Oncology Group | 2011-05-01 |
| Phase 1 PK Study of XOMA 3AB (NCT01357213) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome (NCT01428297) | Novartis Pharmaceuticals | 2011-05-01 |
| Returning to Work. Efficacy of "Tailored Physical Activity or" "Chronic Pain Self-management Program" in Sicklisted Citizens With Chronic Musculoskeletal Pain (NCT01356784) | University of Southern Denmark | 2011-05-01 |
| Intramyocardial Multiple Precision Injection of Bone Marrow Mononuclear Cells in Myocardial Ischemia (NCT01354678) | Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 2011-05-01 |
| A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy Volunteers (NCT01340677) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-05-01 |
| To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses (NCT01332214) | AstraZeneca | 2011-05-01 |
| Phase I Clinical Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of CW002 (NCT01338935) | Weill Medical College of Cornell University | 2011-05-01 |
| Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients (NCT01328522) | Sanofi | 2011-05-01 |
| Improving Care Provided to Patients Treated in a Level 1 Trauma Center Post-suicide Attempt (NCT01355848) | University of Washington | 2011-05-01 |
| Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet (NCT03517033) | Torrent Pharmaceuticals Limited | 2011-05-01 |
| Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers (NCT01358383) | AstraZeneca | 2011-05-01 |
| Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) (NCT01373398) | Handok Inc. | 2011-05-01 |
| Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus (NCT01353040) | Sarepta Therapeutics, Inc. | 2011-05-01 |
| Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy (NCT01405950) | Acorda Therapeutics | 2011-05-01 |
| Evaluation of Obstructive Sleep Apnea With Long Range 3D Endoscopic Fourier Domain Optical Coherence Tomography (FDOCT) (NCT01485497) | University of California, Irvine | 2011-05-01 |
| Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy (NCT01379196) | Rabin Medical Center | 2011-05-01 |
| Platelet-Rich Plasma Therapy for Shoulder Pain in Persons With Spinal Cord Injury (NCT01355549) | Kessler Foundation | 2011-05-01 |
| Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer (NCT01354379) | NanoBio Corporation | 2011-05-01 |